of fields, our leadership team is the source of our success.
Anbio Biotechnology is a global medical technology company dedicated to decentralizing diagnostics and improving patient outcomes through rapid, accessible, and reliable testing solutions. The company offers a comprehensive in vitro diagnostics (IVD) portfolio spanning multiple core technology platforms, including FIA, CLIA, RT-PCR, LFIA, LAMP, and Dry Chemistry. With a growing international presence across Europe, APAC, the Americas, and Africa, Anbio bridges the gap between centralized laboratory testing and point-of-care diagnostics by delivering affordable and clinically reliable testing solutions with rapid turnaround times. Its solutions are designed to support clinical laboratories, point-of-care settings, and at-home wellness applications worldwide. Building on this diagnostic foundation, Anbio is also advancing a growing therapeutics development pipeline, extending its mission from detection to treatment.
